These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23454117)

  • 21. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
    Bender SB; McGraw AP; Jaffe IZ; Sowers JR
    Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses.
    Hoppmann J; Perwitz N; Meier B; Fasshauer M; Hadaschik D; Lehnert H; Klein J
    J Endocrinol; 2010 Feb; 204(2):153-64. PubMed ID: 19939912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury.
    Ayuzawa N; Fujita T
    J Am Soc Nephrol; 2021 Feb; 32(2):279-289. PubMed ID: 33397690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.
    Frigolet ME; Torres N; Tovar AR
    J Nutr Biochem; 2013 Dec; 24(12):2003-15. PubMed ID: 24120291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
    Hirata A; Maeda N; Nakatsuji H; Hiuge-Shimizu A; Okada T; Funahashi T; Shimomura I
    Biochem Biophys Res Commun; 2012 Mar; 419(2):182-7. PubMed ID: 22326264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance.
    Marcus Y; Shefer G; Stern N
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):1-14. PubMed ID: 22750719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome.
    Marzolla V; Armani A; Feraco A; De Martino MU; Fabbri A; Rosano G; Caprio M
    Steroids; 2014 Dec; 91():46-53. PubMed ID: 24819992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of renin-angiotensin system in adipose tissue dysfunction.
    Iwai M; Horiuchi M
    Hypertens Res; 2009 Jun; 32(6):425-7. PubMed ID: 19407825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Respective roles of cortisol, aldosterone and angiotensin II during pathophysiology of atherosclerosis].
    Ayari H
    Ann Biol Clin (Paris); 2013; 71(4):381-8. PubMed ID: 23906564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?
    Engeli S; Schling P; Gorzelniak K; Boschmann M; Janke J; Ailhaud G; Teboul M; Massiéra F; Sharma AM
    Int J Biochem Cell Biol; 2003 Jun; 35(6):807-25. PubMed ID: 12676168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor.
    Caprio M; Zennaro MC; Fève B; Mammi C; Fabbri A; Rosano G
    Climacteric; 2008 Jun; 11(3):258-64. PubMed ID: 18568791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.
    Blaj S; Stanciu S; Jurcut C; Ciobîcă L
    Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of aldosterone and angiotensin II in insulin resistance: an update.
    Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT).
    Agabiti-Rosei C; Paini A; De Ciuceis C; Withers S; Greenstein A; Heagerty AM; Rizzoni D
    Curr Hypertens Rep; 2018 May; 20(5):44. PubMed ID: 29736674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations.
    Boscaro M; Giacchetti G; Ronconi V
    Ann N Y Acad Sci; 2012 Aug; 1264(1):87-102. PubMed ID: 22804097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why are mineralocorticoid receptor antagonists cardioprotective?
    Chai W; Danser AH
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):153-62. PubMed ID: 17075718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical resistance to high-fat diet-induced obesity and altered macrophage polarization in mineralocorticoid receptor-overexpressing mice.
    Kuhn E; Bourgeois C; Keo V; Viengchareun S; Muscat A; Meduri G; Le Menuet D; Fève B; Lombès M
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(1):E75-90. PubMed ID: 24222670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.